Consolidative Stereotactic Ablative Radiotherapy to the Residual Primary Tumor after First-line Systemic Therapy: Impact on New Distant Metastases in Advanced Non–Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e755
DOI: 10.1016/j.ijrobp.2026.06.2289 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von D. Tao und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tao, D., Sun, L., Yang, L., Wang, L., Jiang, Y., Zhou, W., Wang, Y., & Wu, Y. (2026). Consolidative Stereotactic Ablative Radiotherapy to the Residual Primary Tumor after First-line Systemic Therapy: Impact on New Distant Metastases in Advanced Non–Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics, 126(1), e755. https://doi.org/10.1016/j.ijrobp.2026.06.2289
Vancouver
Tao D, Sun L, Yang L, Wang L, Jiang Y, Zhou W, et al. Consolidative Stereotactic Ablative Radiotherapy to the Residual Primary Tumor after First-line Systemic Therapy: Impact on New Distant Metastases in Advanced Non–Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e755. doi:10.1016/j.ijrobp.2026.06.2289
BibTeX
@article{Tao2026,
author = {Tao, D. and Sun, L. and Yang, L. and Wang, L. and Jiang, Y. and Zhou, W. and Wang, Y. and Wu, Y.},
title = {Consolidative Stereotactic Ablative Radiotherapy to the Residual Primary Tumor after First-line Systemic Therapy: Impact on New Distant Metastases in Advanced Non–Small Cell Lung Cancer},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {e755},
doi = {10.1016/j.ijrobp.2026.06.2289}
}
EUVIMED